• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对疟疾免疫中环子孢子蛋白的补体固定作用的抗体靶点和特性。

Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity.

机构信息

Life Sciences, Burnet Institute, Melbourne, VIC, Australia.

Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia.

出版信息

Front Immunol. 2021 Dec 1;12:775659. doi: 10.3389/fimmu.2021.775659. eCollection 2021.

DOI:10.3389/fimmu.2021.775659
PMID:34925347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8671933/
Abstract

The circumsporozoite protein (CSP) forms the basis of leading subunit malaria vaccine candidates. However, the mechanisms and specific targets of immunity are poorly defined. Recent findings suggest that antibody-mediated complement-fixation and activation play an important role in immunity. Here, we investigated the regions of CSP targeted by functional complement-fixing antibodies and the antibody properties associated with this activity. We quantified IgG, IgM, and functional complement-fixing antibody responses to different regions of CSP among Kenyan adults naturally exposed to malaria (n=102) and using a series of rabbit vaccination studies. Individuals who acquired functional complement-fixing antibodies had higher IgG, IgM and IgG1 and IgG3 to CSP. Acquired complement-fixing antibodies targeted the N-terminal, central-repeat, and C-terminal regions of CSP, and positive responders had greater antibody breadth compared to those who were negative for complement-fixing antibodies (p<0.05). Using rabbit vaccinations as a model, we confirmed that IgG specific to the central-repeat and non-repeat regions of CSP could effectively fix complement. However, vaccination with near full length CSP in rabbits poorly induced antibodies to the N-terminal region compared to naturally-acquired immunity in humans. Poor induction of N-terminal antibodies was also observed in a vaccination study performed in mice. IgG and IgM to all three regions of CSP play a role in mediating complement-fixation, which has important implications for malaria vaccine development.

摘要

环子孢子蛋白(CSP)是主要亚单位疟疾疫苗候选物的基础。然而,免疫的机制和特定靶点尚未明确。最近的研究结果表明,抗体介导的补体固定和激活在免疫中发挥重要作用。在这里,我们研究了功能性补体固定抗体靶向的 CSP 区域以及与该活性相关的抗体特性。我们定量了肯尼亚成年人自然感染疟疾(n=102)和一系列兔疫苗接种研究中对 CSP 不同区域的 IgG、IgM 和功能性补体固定抗体反应。获得功能性补体固定抗体的个体对 CSP 的 IgG、IgM 和 IgG1 和 IgG3 的反应更高。获得的补体固定抗体靶向 CSP 的 N 端、中央重复和 C 端区域,与补体固定抗体阴性的个体相比,阳性反应者的抗体广度更大(p<0.05)。使用兔疫苗接种作为模型,我们证实针对 CSP 的中央重复和非重复区域的 IgG 特异性可有效固定补体。然而,与人类自然获得的免疫力相比,兔中的全长 CSP 疫苗接种对 N 端区域的抗体诱导作用较差。在在小鼠中进行的疫苗接种研究中也观察到 N 端抗体的诱导作用较差。针对 CSP 的所有三个区域的 IgG 和 IgM 都在介导补体固定中发挥作用,这对疟疾疫苗的开发具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/facf/8671933/8baef27500bc/fimmu-12-775659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/facf/8671933/32f92d25c5d3/fimmu-12-775659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/facf/8671933/9a51b4b78562/fimmu-12-775659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/facf/8671933/27d46acae234/fimmu-12-775659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/facf/8671933/9775ce6090fb/fimmu-12-775659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/facf/8671933/8baef27500bc/fimmu-12-775659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/facf/8671933/32f92d25c5d3/fimmu-12-775659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/facf/8671933/9a51b4b78562/fimmu-12-775659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/facf/8671933/27d46acae234/fimmu-12-775659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/facf/8671933/9775ce6090fb/fimmu-12-775659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/facf/8671933/8baef27500bc/fimmu-12-775659-g005.jpg

相似文献

1
Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity.针对疟疾免疫中环子孢子蛋白的补体固定作用的抗体靶点和特性。
Front Immunol. 2021 Dec 1;12:775659. doi: 10.3389/fimmu.2021.775659. eCollection 2021.
2
Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure.RTS,S 疟疾疫苗在儿童中诱导和衰减功能性补体结合抗体,并受到疟疾暴露的负面影响。
BMC Med. 2019 Feb 25;17(1):45. doi: 10.1186/s12916-019-1277-x.
3
Antibody mechanisms of protection against malaria in RTS,S-vaccinated children: a post-hoc serological analysis of phase 2 trial.RTS,S 疫苗接种儿童抗疟疾的抗体机制: 2 期试验的事后血清学分析。
Lancet Microbe. 2024 Oct;5(10):100898. doi: 10.1016/S2666-5247(24)00130-7. Epub 2024 Aug 7.
4
Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children.基线暴露、抗体亚类和乙型肝炎反应对 RTS,S/AS01E 疫苗接种后非洲儿童疟疾保护免疫的影响不同。
BMC Med. 2018 Oct 31;16(1):197. doi: 10.1186/s12916-018-1186-4.
5
Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M.诱导和补体固定抗体对恶性疟原虫裂殖子表面蛋白 3α的动力学与免疫球蛋白 G 亚类和免疫球蛋白 M 的关系。
J Infect Dis. 2019 Nov 6;220(12):1950-1961. doi: 10.1093/infdis/jiz407.
6
Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children.人体抗体可激活补体针对疟原虫孢子,与儿童疟疾保护有关。
BMC Med. 2018 Apr 30;16(1):61. doi: 10.1186/s12916-018-1054-2.
7
Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.疟前免疫志愿者接种 PfSPZ 疫苗可诱导产生长寿命 IgM 入侵抑制和补体结合抗体。
J Infect Dis. 2018 Apr 23;217(10):1569-1578. doi: 10.1093/infdis/jiy080.
8
A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.一种基于单克隆抗体的免疫测定法,用于检测针对恶性疟原虫环子孢子蛋白重复区域的抗体反应。
Malar J. 2016 Nov 8;15(1):543. doi: 10.1186/s12936-016-1596-8.
9
Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Is Immunogenic and Induces Functional Antibody Responses in Mice.新型病毒样颗粒疫苗编码疟原虫环子孢子蛋白,具有免疫原性,能诱导小鼠产生功能性抗体应答。
Front Immunol. 2021 Mar 17;12:641421. doi: 10.3389/fimmu.2021.641421. eCollection 2021.
10
IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.针对临床级恶性疟原虫环子孢子蛋白(CSP)疫苗抗原的IgG2抗体与小鼠抵抗转基因子孢子攻击的保护作用相关。
PLoS One. 2014 Oct 24;9(10):e111020. doi: 10.1371/journal.pone.0111020. eCollection 2014.

引用本文的文献

1
R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.R21/Matrix-M疟疾疫苗在既往接触过疟疾的成年人中引发多种免疫反应:来自一项IIb期人类疟疾感染对照试验的见解
Front Immunol. 2025 Jul 7;16:1620365. doi: 10.3389/fimmu.2025.1620365. eCollection 2025.
2
Development of high affinity antibodies to merozoite and sporozoite antigens during infancy and adulthood.婴儿期和成年期针对裂殖子和子孢子抗原的高亲和力抗体的产生。
Front Immunol. 2025 Jul 2;16:1562671. doi: 10.3389/fimmu.2025.1562671. eCollection 2025.
3
Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.

本文引用的文献

1
Recent clinical trials inform the future for malaria vaccines.近期的临床试验为疟疾疫苗的未来发展提供了信息。
Commun Med (Lond). 2021 Aug 25;1:26. doi: 10.1038/s43856-021-00030-2. eCollection 2021.
2
Multi-functional antibody profiling for malaria vaccine development and evaluation.多功能抗体分析在疟疾疫苗研发和评价中的应用。
Expert Rev Vaccines. 2021 Oct;20(10):1257-1272. doi: 10.1080/14760584.2021.1981864. Epub 2021 Oct 25.
3
Reduced risk of placental parasitemia associated with complement fixation on Plasmodium falciparum by antibodies among pregnant women.
针对疟疾传播的瓶颈:抗体-表位描述指导下一代生物医学干预措施的设计。
Immunol Rev. 2025 Mar;330(1):e70001. doi: 10.1111/imr.70001.
4
Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development.探索恶性疟原虫环子孢子蛋白上的新型表位以用于疫苗开发。
NPJ Vaccines. 2024 Nov 18;9(1):225. doi: 10.1038/s41541-024-01006-8.
5
Identification of RTS,S/AS01 vaccine-induced humoral biomarkers predictive of protection against controlled human malaria infection.鉴定 RTS,S/AS01 疫苗诱导的体液生物标志物,预测其对人体疟疾感染的保护作用。
JCI Insight. 2024 Oct 8;9(19):e178801. doi: 10.1172/jci.insight.178801.
6
Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention.针对环子孢子蛋白的单克隆抗体作为一种新兴的疟疾预防工具。
Nat Immunol. 2024 Sep;25(9):1530-1545. doi: 10.1038/s41590-024-01938-2. Epub 2024 Aug 28.
7
Geospatial joint modeling of vector and parasite serology to microstratify malaria transmission.基于地理空间的媒介和寄生虫血清联合建模来细分疟疾传播。
Proc Natl Acad Sci U S A. 2024 Jun 11;121(24):e2320898121. doi: 10.1073/pnas.2320898121. Epub 2024 Jun 4.
8
IgG and IgM responses to the Plasmodium falciparum asexual stage antigens reflect respectively protection against malaria during pregnancy and infanthood.IgG 和 IgM 对恶性疟原虫无性体抗原的反应分别反映了妊娠和婴儿期期间对疟疾的保护作用。
Malar J. 2024 May 19;23(1):154. doi: 10.1186/s12936-024-04970-7.
9
Genetic polymorphism and evidence of signatures of selection in the Plasmodium falciparum circumsporozoite protein gene in Tanzanian regions with different malaria endemicity.在疟疾流行程度不同的坦桑尼亚地区,对疟原虫环子孢子蛋白基因的遗传多态性和选择信号的证据进行研究。
Malar J. 2024 May 8;23(1):139. doi: 10.1186/s12936-024-04974-3.
10
Poly I:C elicits broader and stronger humoral and cellular responses to a circumsporozoite protein malaria vaccine than Alhydrogel in mice.聚肌胞苷酸(Poly I:C)比氢氧化铝佐剂在小鼠中引发更广泛和更强的针对疟原虫环子孢子蛋白疫苗的体液和细胞反应。
Front Immunol. 2024 Apr 8;15:1331474. doi: 10.3389/fimmu.2024.1331474. eCollection 2024.
孕妇体内针对疟原虫的抗体引起的补体固定可降低胎盘寄生虫血症的风险。
BMC Med. 2021 Aug 24;19(1):201. doi: 10.1186/s12916-021-02061-x.
4
A guide to investigating immune responses elicited by whole-sporozoite pre-erythrocytic vaccines against malaria.调查全孢子期前血期疫苗诱导的疟疾免疫应答的指南。
FEBS J. 2022 Jun;289(12):3335-3359. doi: 10.1111/febs.16016. Epub 2021 Jun 1.
5
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.低剂量候选疟疾疫苗 R21 联合 Matrix-M 佐剂,季节性接种在布基纳法索儿童中的效果:一项随机对照试验。
Lancet. 2021 May 15;397(10287):1809-1818. doi: 10.1016/S0140-6736(21)00943-0. Epub 2021 May 5.
6
Mechanisms and targets of Fcγ-receptor mediated immunity to malaria sporozoites.Fcγ受体介导的抗疟原虫子孢子免疫的机制与靶点。
Nat Commun. 2021 Mar 19;12(1):1742. doi: 10.1038/s41467-021-21998-4.
7
Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a Trial.RTS,S 疟疾疫苗诱导产生多功能抗体,并在 1/2a 期临床试验中具有保护作用。
J Infect Dis. 2021 Oct 13;224(7):1128-1138. doi: 10.1093/infdis/jiaa144.
8
IgM in human immunity to malaria.人对疟疾的免疫中的 IgM。
Sci Adv. 2019 Sep 25;5(9):eaax4489. doi: 10.1126/sciadv.aax4489. eCollection 2019 Sep.
9
Complement in malaria immunity and vaccines.补体在疟疾免疫和疫苗中的作用。
Immunol Rev. 2020 Jan;293(1):38-56. doi: 10.1111/imr.12802. Epub 2019 Sep 26.
10
Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure.RTS,S 疟疾疫苗在儿童中诱导和衰减功能性补体结合抗体,并受到疟疾暴露的负面影响。
BMC Med. 2019 Feb 25;17(1):45. doi: 10.1186/s12916-019-1277-x.